Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 6.42% | 282.35 | 0.0% | $4047.51m | |
| BNTX | BioNTech SE | 8.17% | 302.69 | 0.0% | $1321.33m | |
| NVAX | Novavax, Inc. | 28.90% | 182.85 | 78.2% | $874.24m | |
| AMGN | Amgen, Inc. | 1.21% | 211.32 | 1.4% | $643.80m | |
| GILD | Gilead Sciences, Inc. | 0.22% | 69.65 | 1.0% | $510.30m | |
| LGVN | Longeveron Inc. | -3.31% | 19.58 | 0.0% | $453.36m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.08% | 205.22 | 1.9% | $451.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.61% | 635.09 | 2.7% | $406.05m | |
| ILMN | Illumina, Inc. | 5.06% | 369.43 | 3.3% | $341.03m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 2.38% | 4.31 | 0.7% | $301.28m | |
| BIIB | Biogen, Inc. | 1.21% | 226.83 | 1.8% | $284.75m | |
| SGEN | Seagen Inc. | 0.30% | 146.44 | 5.8% | $152.49m | |
| INCY | Incyte Corp. | 2.65% | 66.73 | 2.4% | $150.12m | |
| EXAS | EXACT Sciences Corp. | 3.12% | 83.36 | 18.0% | $145.51m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.23% | 86.12 | 4.2% | $137.03m |
Company Profile
Viracta Therapeutics, Inc. a clinical-stage, biomarker-directed precision oncology company focused on new medicines for the treatment of virus-associated malignancies. It develops antiviral agent valganciclovir as an oral combination therapy which is in a Phase 2 clinical trial for EBV-positive lymphomas. The company was founded on February 10, 1998 and is headquartered in Cardiff, CA.